Literature DB >> 18220938

Mechanisms of intimal hyperplasia learned from a murine carotid artery ligation model.

Le-Ning Zhang1, John F Parkinson, Christopher Haskell, Yi-Xin Wang.   

Abstract

The murine carotid artery ligation (CAL) model has been widely used in the research of intimal hyperplasia, a major pathological process in vascular diseases, such as atherosclerosis and restenosis after angioplasty. Using a variety of gene knockout or transgenic mice and different pharmacological interventions, these studies have yielded significant new findings that contribute not only to unraveling the basic molecular mechanisms involved in the pathogenesis of intimal hyperplasia, but also to the identification of novel targets for intervention of these diseases. The current review outlines the findings derived from the murine CAL model, including studies run by the authors, covering the impacts of hyperlipidemia, pro-inflammatory factors, endothelial dysfunction, protease activity and growth mediators on neointimal hyperplasia.

Entities:  

Mesh:

Year:  2008        PMID: 18220938     DOI: 10.2174/157016108783331321

Source DB:  PubMed          Journal:  Curr Vasc Pharmacol        ISSN: 1570-1611            Impact factor:   2.719


  10 in total

1.  A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application.

Authors:  Nicholas E Buglak; Edward S M Bahnson
Journal:  J Vis Exp       Date:  2020-07-09       Impact factor: 1.355

2.  Calreticulin Regulates Neointima Formation and Collagen Deposition following Carotid Artery Ligation.

Authors:  Kurt A Zimmerman; Dongqi Xing; Manuel A Pallero; Ailing Lu; Masahito Ikawa; Leland Black; Kenneth L Hoyt; Janusz H Kabarowski; Marek Michalak; Joanne E Murphy-Ullrich
Journal:  J Vasc Res       Date:  2016-02-25       Impact factor: 1.934

3.  Transglutaminase 2 promotes PDGF-mediated activation of PDGFR/Akt1 and β-catenin signaling in vascular smooth muscle cells and supports neointima formation.

Authors:  Maria Nurminskaya; Kelly E Beazley; Elizabeth P Smith; Alexey M Belkin
Journal:  J Vasc Res       Date:  2015-01-22       Impact factor: 1.934

Review 4.  Animal, in vitro, and ex vivo models of flow-dependent atherosclerosis: role of oxidative stress.

Authors:  Amir Rezvan; Chih-Wen Ni; Noah Alberts-Grill; Hanjoong Jo
Journal:  Antioxid Redox Signal       Date:  2010-12-04       Impact factor: 8.401

Review 5.  PAI-1: A Major Player in the Vascular Dysfunction in Obstructive Sleep Apnea?

Authors:  Mohammad Badran; David Gozal
Journal:  Int J Mol Sci       Date:  2022-05-15       Impact factor: 6.208

6.  Systemic inflammation as a predictor of clinical outcomes after lower extremity angioplasty/stenting.

Authors:  Kenneth DeSart; Kerri O'Malley; Bradley Schmit; Maria-Cecilia Lopez; Lyle Moldawer; Henry Baker; Scott Berceli; Peter Nelson
Journal:  J Vasc Surg       Date:  2015-06-06       Impact factor: 4.268

7.  Exposure to experimental preeclampsia in mice enhances the vascular response to future injury.

Authors:  Dafina Pruthi; Eliyahu V Khankin; Robert M Blanton; Mark Aronovitz; Suzanne D Burke; Amy McCurley; S Ananth Karumanchi; Iris Z Jaffe
Journal:  Hypertension       Date:  2015-02-23       Impact factor: 10.190

8.  Phosphatidic acid generated by PLD2 promotes the plasma membrane recruitment of IQGAP1 and neointima formation.

Authors:  Ziqing Wang; Ming Cai; Li Wei Rachel Tay; Feng Zhang; Ping Wu; Anh Huynh; Xiumei Cao; Gilbert Di Paolo; Junmin Peng; Dianna M Milewicz; Guangwei Du
Journal:  FASEB J       Date:  2019-02-27       Impact factor: 5.834

9.  High expression of ubiquitin-specific peptidase 39 is associated with the development of vascular remodeling.

Authors:  Shuai He; Wei Zhong; Li Yin; Yifei Wang; Zhibing Qiu; Gang Song
Journal:  Mol Med Rep       Date:  2017-03-08       Impact factor: 2.952

10.  Opposing Effects on Vascular Smooth Muscle Cell Proliferation and Macrophage-induced Inflammation Reveal a Protective Role for the Proresolving Lipid Mediator Receptor ChemR23 in Intimal Hyperplasia.

Authors:  Gonzalo Artiach; Miguel Carracedo; Joan Clària; Andres Laguna-Fernandez; Magnus Bäck
Journal:  Front Pharmacol       Date:  2018-11-20       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.